Provisio Medical

Executive Summary

Provisio Medical is a development-stage medical device company headquartered in Austin, Texas, founded in 2017. The company is pioneering Sonic Lumen Tomography (SLT™), a novel intravascular ultrasound (IVUS) technology designed to provide real-time, accurate vessel sizing without requiring user interpretation. This innovation aims to enhance procedural workflows and improve clinical outcomes in endovascular procedures. Currently in the pre-commercial phase, Provisio has not disclosed total funding or valuation, indicating an early-stage profile. The SLT platform addresses a critical need for precision in vascular interventions, potentially reducing complications and procedure times. As the company advances toward commercialization, key milestones include regulatory submissions, clinical data generation, and strategic partnerships. Given the competitive landscape of IVUS and the growing adoption of image-guided therapies, Provisio's success hinges on demonstrating superior accuracy and workflow benefits over existing technologies.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for SLT catheter system70% success
• Q2 2026Series B funding round to support clinical studies and commercial launch60% success
• Q3 2026First-in-human clinical results demonstrating accuracy superiority over traditional IVUS50% success